3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
35
Terminated
5
Unknown
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
4
Breast Neoplasms
3
Stomach Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Tongue Squamous Cell Carcinoma
1
Squamous Non-Small Cell Lung Cancer SqNSCLC
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Resectable Esophageal Squamous Cell Carcinoma
1
Rare Tumour
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Hypoxia
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Biliary Tract Neoplasms
1
Advanced Non-squamous Non-small-cell Lung Cancer
1
Interventions
Exercise
8
Standard of Care
5
trametinib
3
tislelizumab
3
Radiotherapy
3
Radiosurgery
3
Palliative Care
3
Paclitaxel
3
Gemcitabine
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
cemiplimab
2
Therapeutics
2
Surveys and Questionnaires
2
Resistance Training
2
Oxaliplatin
2
Nivolumab
2
Maintenance
2
Immune Checkpoint Inhibitors
2
Drug Therapy
2
Cisplatin
2
Carboplatin
2
zanidatamab
1
vedolizumab
1
toripalimab
1
surufatinib
1
sparsentan
1
sintilimab
1
semaglutide
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasms
×
Albumin-Bound Paclitaxel
×
Clear all
NCT07578337
2026-05-13
NUMANTIA-2
Nelum Corp
Phase 2
Not yet recruiting
40 enrolled